Intellia Therapeutics Inc sell StockNews.com
Start price
30.11.25
/
50%
€7.77
Target price
30.11.26
-
Performance (%)
42.70%
Price
08:30
€11.09
Summary
This prediction is currently active. The SELL prediction by StockNews_com for Intellia Therapeutics Inc is trending in the completely wrong direction and now has a performance of 42.70%. This prediction currently runs until 30.11.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | -10.385% | -10.385% |
| iShares Core DAX® | -0.559% | 0.738% |
| iShares Nasdaq 100 | -0.566% | -0.324% |
| iShares Nikkei 225® | 1.073% | 5.624% |
| iShares S&P 500 | 0.868% | 0.030% |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NASDAQ:NTLA) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.51
11.05.24
11.05.24
-
11.05.25
11.05.25
-67.08%
12.05.25
12.05.25